| CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY |
Note 21
— CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
Regulation S-X
requires the condensed financial information of registrant shall be filed when the restricted net assets of consolidated subsidiaries
exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. For purposes of the above test,
restricted net assets of consolidated subsidiaries shall mean that amount of the registrant’s proportionate share of net assets
of consolidated subsidiaries (after intercompany eliminations) of which as of the end of the most recent fiscal year may not be transferred
to the parent company by subsidiaries in the form of loans, advances or cash dividends without the consent of a third party. The condensed
parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X as
the restricted net assets of the Company’s PRC VIE and VIE’s subsidiaries exceed 25% of the consolidated net assets of the
Company. Certain
information and footnote disclosures normally included in financial statements prepared in conformity with U.S. GAAP have been condensed
or omitted. The Company’s investment in subsidiary is stated at cost plus equity in undistributed earnings of subsidiaries.
Loss
in excess of Investment in subsidiaries, VIE and VIE’s subsidiaries, on the Condensed Balance Sheets, is comprised of the Parent
Company’s net investment in its subsidiaries, VIE and VIE’s subsidiaries under the equity method of accounting.
Condensed
Balance Sheets
| | |
As
of December 31, | |
| | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| ASSETS | |
| | |
| | |
| |
| Cash
and cash equivalents | |
| 54,971 | | |
| 128,663 | | |
| 18,399 | |
| Other
receivables, net | |
| — | | |
| 57,693,075 | | |
| 8,250,000 | |
| Amount
due from related parties | |
| — | | |
| 46,364,252 | | |
| 6,630,000 | |
| Advances
to suppliers | |
| — | | |
| — | | |
| — | |
| Long-term
Investment | |
| — | | |
| 993,020 | | |
| 142,000 | |
| Total
assets | |
| 54,971 | | |
| 105,179,010 | | |
| 15,040,399 | |
| | |
| | | |
| | | |
| | |
| LIABILITIES
AND SHAREHOLDERS’ EQUITY | |
| | | |
| | | |
| | |
| Accrued
liabilities | |
| — | | |
| 349,655 | | |
| 50,000 | |
| Amount
due to a related party | |
| 437,958 | | |
| — | | |
| — | |
| Total
current liabilities | |
| 437,958 | | |
| 349,655 | | |
| 50,000 | |
| Non-current
liabilities | |
| | | |
| | | |
| | |
| Loss
in excess of investment in subsidiaries, VIE and VIE’s subsidiaries | |
| 667,987,375 | | |
| 558,809,528 | | |
| 79,908,701 | |
| Total
non-current liabilities | |
| 667,987,375 | | |
| 558,809,528 | | |
| 79,908,701 | |
| Total
liabilities | |
| 668,425,333 | | |
| 559,159,183 | | |
| 79,958,701 | |
| | |
| | | |
| | | |
| | |
| Commitments
and contingencies | |
| — | | |
| — | | |
| — | |
| Mezzanine
equity | |
| | | |
| | | |
| | |
| Convertible
redeemable preferred shares | |
| 1,595,051,558 | | |
| — | | |
| — | |
| Shareholders’ deficit: | |
| | | |
| | | |
| | |
Class A Ordinary shares (US$0.0001 par value; 450,000,000 shares authorized, 4,268,156 and 21,140,922 shares issued and outstanding as of December 31, 2024 and 2025, respectively) | |
| 2,988 | | |
| 14,997 | | |
| 2,145 | |
Class B Ordinary shares (US$0.0001 par value; 2,042,042 shares authorized and outstanding as of December 31, 2024 and 2025, respectively) | |
| 1,408 | | |
| 1,408 | | |
| 201 | |
| Subscription
receivable | |
| (1,608 | ) | |
| (2,186 | ) | |
| (313 | ) |
| Additional
paid-in capital | |
| — | | |
| 2,023,765,569 | | |
| 289,394,627 | |
| Accumulated
deficit | |
| (2,263,419,477 | ) | |
| (2,475,998,594 | ) | |
| (354,063,090 | ) |
| Accumulated
other comprehensive loss | |
| (5,231 | ) | |
| (1,761,367 | ) | |
| (251,872 | ) |
| Total
deficit | |
| (2,263,421,920 | ) | |
| (453,980,173 | ) | |
| (64,918,302 | ) |
| Total
liabilities, mezzanine equity and deficit | |
| 54,971 | | |
| 105,179,010 | | |
| 15,040,399 | |
| * | Ordinary
shares and share data have been retroactively restated to give effect to the nominal share
issuance for the Reorganization completed on August 8, 2024 (Note 1). |
Condensed
Statements of Operations and Comprehensive Loss
| | |
Years
ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Operating
costs and expenses: | |
| | |
| | |
| | |
| |
| Selling,
general and administrative | |
| — | | |
| (377,756 | ) | |
| (49,347,867 | ) | |
| (7,056,651 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Operating
loss | |
| | | |
| | | |
| | | |
| | |
| Equity
loss in subsidiaries, VIEs and VIEs’ subsidiaries | |
| (36,950,478 | ) | |
| (37,013,556 | ) | |
| (81,582,534 | ) | |
| (11,666,147 | ) |
| Net
loss | |
| (36,950,478 | ) | |
| (37,391,312 | ) | |
| (130,930,401 | ) | |
| (18,722,798 | ) |
| Accretion
to redemption value of mezzanine equities | |
| (108,440,354 | ) | |
| (105,969,614 | ) | |
| (81,648,716 | ) | |
| (11,675,611 | ) |
| Net
loss attributable to ordinary shareholders | |
| (145,390,832 | ) | |
| (143,360,926 | ) | |
| (212,579,117 | ) | |
| (30,398,409 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Other
comprehensive income | |
| | | |
| | | |
| | | |
| | |
| Foreign
currency translation adjustments | |
| — | | |
| (5,231 | ) | |
| (1,747,229 | ) | |
| (249,850 | ) |
| Total
other comprehensive loss | |
| — | | |
| (5,231 | ) | |
| (1,747,229 | ) | |
| (249,850 | ) |
| Total
Comprehensive loss | |
| (145,390,832 | ) | |
| (143,366,157 | ) | |
| (214,326,346 | ) | |
| (30,648,259 | ) |
Condensed
Statements of Cash Flows
| | |
Year
ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Cash
flows from operating activities: | |
| | |
| | |
| | |
| |
| Net
loss | |
| (36,950,478 | ) | |
| (37,391,312 | ) | |
| (130,930,401 | ) | |
| (18,722,798 | ) |
| Adjustments
to reconcile net loss to net cash used in operating activities: | |
| | | |
| | | |
| | | |
| | |
| Equity
loss in subsidiaries, VIEs and VIEs’ subsidiaries | |
| 36,950,478 | | |
| 37,013,556 | | |
| 81,582,534 | | |
| 11,666,147 | |
| Share base payment | |
| — | | |
| — | | |
| 16,423,683 | | |
| 2,348,555 | |
| Changes
in operating liabilities: | |
| | | |
| | | |
| | | |
| | |
| Other
receivables | |
| — | | |
| — | | |
| (57,693,075 | ) | |
| (8,250,000 | ) |
| Amount
due from a related party | |
| 35,500 | | |
| 402,458 | | |
| (46,364,252 | ) | |
| (6,630,000 | ) |
| Accrued liabilities | |
| | | |
| | | |
| 349,655 | | |
| 50,000 | |
| Amount
due to a related party | |
| — | | |
| — | | |
| (437,958 | ) | |
| (62,626 | ) |
| Net
cash provided by operating activities | |
| 35,500 | | |
| 24,702 | | |
| (137,069,814 | ) | |
| (19,600,722 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash
flows from investing activities: | |
| | | |
| | | |
| | | |
| | |
| Payment
for investment in a subsidiary | |
| — | | |
| — | | |
| (993,020 | ) | |
| (142,000 | ) |
| Net
cash used in investing activities | |
| — | | |
| — | | |
| (993,020 | ) | |
| (142,000 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash
flows from financing activities: | |
| | | |
| | | |
| | | |
| | |
| Net
proceeds from IPO | |
| — | | |
| — | | |
| 163,932,614 | | |
| 23,442,051 | |
| Payment
for deferred offering cost | |
| — | | |
| — | | |
| (23,876,547 | ) | |
| (3,414,300 | ) |
| Net
cash provided by financing activities | |
| — | | |
| — | | |
| 140,056,067 | | |
| 20,027,751 | |
| | |
| | | |
| | | |
| | | |
| | |
| Effect
of exchange rate change | |
| — | | |
| (5,231 | ) | |
| (1,919,541 | ) | |
| (274,491 | ) |
| Net
increase in cash and cash equivalents | |
| 35,500 | | |
| 19,471 | | |
| 73,692 | | |
| 10,538 | |
| Cash
and cash equivalents at beginning of the years | |
| — | | |
| 35,500 | | |
| 54,971 | | |
| 7,861 | |
| Cash
and cash equivalents at end of the years | |
| 35,500 | | |
| 54,971 | | |
| 128,663 | | |
| 18,399 | |
|